Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study.

Razavi-Shearer D., Gamkrelidze I., Nguyen M. H. , Chen D., Van Damme P., Abbas Z., ...More

The lancet. Gastroenterology & hepatology, vol.3, no.6, pp.383-403, 2018 (Journal Indexed in SCI Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 3 Issue: 6
  • Publication Date: 2018
  • Doi Number: 10.1016/s2468-1253(18)30056-6
  • Title of Journal : The lancet. Gastroenterology & hepatology
  • Page Numbers: pp.383-403


Background The 69th World Health Assembly approved the Global Health Sector Strategy to eliminate viral hepatitis by 2030. Although no virological cure exists for hepatitis B virus (HBV) infection, existing therapies to control viral replication and prophylaxis to minimise mother-to-child transmission make elimination of HBV feasible. We aimed to estimate the national, regional, and global prevalence of HBsAg in the general population and in the population aged 5 years in 2016, as well as coverage of prophylaxis, diagnosis, and treatment.